ESR1 and breast carcinoma: We first generated dose-response curves of MRT for the ERα+ breast cancer cell lines MCF7, T47D, and MCF7-V; the tamoxifen-resistant cell lines MCF7/LCC2 and MCF7/TamR (53, 54); and the noncancerous breast epithelial cell line MCF10A (fig.